VenatoRx Pharmaceuticals' Series B Round

VenatoRx Pharmaceuticals raised a round of funding on July 25, 2017.

VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents. The company's goal is to identify and progress into clin…

Articles about VenatoRx Pharmaceuticals' Series B Round: